Abstract
In the seventeenth century it was commonly held that asthma was a nervous disease. Sir John Floyer believed that an attack of asthma occured when “nerves are filled with windy spirits” (Floyer 1698). Hyde Salter, in his brilliant description of asthma more than 100 years ago, wrote that “in asthma, there is no peculiarity in the stimulus, the air breathed in is the same in the asthmatic and the non-asthmatic…nor, probably, is there any peculiarity in the irritability of bronchial muscle; the peculiarity is confined to the link that connects these two — the nervous system — and consists in its perverse sensibility, in its receiving and transmitting on to the muscle, as a stimulus to contraction, that of which it should take cognizance…it is clear that the vice in asthma consists not in the production of any special irritant but in the irritability of the part irritated” (Salter 1868). Thus, asthma was seen as a disease of excessive irritability of the airways produced by neural mechanisms. Later, immunological theories of asthma gained favour and there was an emphasis on inflammatory mediators and mast cells. More recently there has been a re-awakening of interest in neurogenic mechanisms in asthma, now that it is clear that there is a complex interaction between inflammation and neural control of airways.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Advenier C, Naline E, Drapeau G, Regoli D (1987) Relative potencies of neurokinins in guinea-pig and human bronchus. Eur J Pharmacol 139: 133–137
Alexander HL, Paddock R (1921) Bronchial asthma: response to pilocarpine and epinephrine. Arch Intern Med 27: 184–191
Andersson RGG, Grundstrom N (1983) The excitatory non-cholinergic, non- adrenergic nervous system of the guinea-pig airways. Eur J Respir Dis 64: 141–157
Andersson RGG, Fugner A, Lundgren BR, Muacevic G (1986) Inhibitory effects of elonidine on bronchospasm induced in guinea-pig by vagal stimulation or antigen challenge. Eur J Pharmacol 123: 181–185
Barnes PJ (1986a) State of art. Neural control of human airways in health and disease. Am Rev Respir Dis 134: 1289–1314
Barnes PJ (1986b) Endogenous catecholamines and asthma. J Allergy Clin Immunol 77: 791–795
Barnes PJ (1986c) Non-adrenergic non-cholinergic neural control of human airways. Arch Int Pharmacodyn 280 [Suppl]: 208–228
Barnes PJ (1986d) Airway inflammation and autonomic control. Eur J Respir Dis 69 [Suppl 147]: 80–87
Barnes PJ (1986e) Asthma as an axon reflex. Lancet i: 242–245
Barnes PJ (1987a) Airway neuropeptides and asthma. Trends Pharm Sci 8: 24–27
Barnes PJ (1987b) Muscarinic receptors in lung. Postgrad Med J 63: [Suppl]: 13–19
Barnes PJ (1987c) Neuropeptides in the lung: localization, function and pathophysiologic implications. J Allergy Clin Immunol 79: 285–295
Barnes PJ. (1987d) Cholinergic control of airway smooth muscle. Am Rev Respir Dis 136: S42–45
Barnes PJ (1987e) Neuropeptides in human airways: function and clinical implications. Am Rev Respir Dis 136: S77–83
Barnes PJ (1988) Adrenergic regulation of airway function. In:Kaliner MA, Barnes PJ (eds) The airways: neural control in health and disease. Dekker, New York, pp 57–85
Barnes PJ (1989) Muscarinic receptor subtypes: implications for lung disease. Thorax 44: 161–167
Barnes PJ, Lundberg JM (1990) Airway neuropeptides and asthma. In: Kaliner M, Barnes PJ, Persson CGA (eds) Asthma and bronchial hyperresponsiveness: pathogenesis and treatment. Dekker, New York (in press)
Barnes PJ, Dollery CT, MacDermot J (1980) Increased pulmonary a-adrenergic and reduced (3-adrenergic receptors in experimental asthma. Nature 285: 569–571
Barnes PJ, Brown MJ, Silverman M, Dollery CT (1981a) Circulating catecholamines in exercise and hyperventilation-induced asthma. Thorax 36: 435–440
Barnes PJ, Ind PW, Dollery CT (1981b) Inhaled prazosin in asthma. Thorax 36: 378–381
Barnes PJ, Wilson NM, Vickers H (1981c) Prazosin, an alphal-adrenoceptor antagonist partially inhibits exercise-induced asthma. J Allergy Clin Immunol 68: 411–419
Barnes PJ, Basbaum CB, Nadel JA, Roberts JM (1982a) Localization of P- adrenoceptors in mammalian lung by light microscopic autoradiography. Nature 299: 444–447.
Barnes PJ, Ind PW, Brown MJ (1982b) Plasma histamine and catecholamines in stable asthmatic subjects. Clin Sci 62: 661–665
Barnes PJ, Basbaum CB, Nadel JA (1983a) Autoradiographic localization of autonomic receptors in airway smooth muscle: marked differences between large and small airways. Am Rev Respir Dis 127: 758–762
Barnes PJ, Skoogh B-E, Nadel JA, Roberts JM (1983b) Postsynaptic a2- adrenoceptors predominate over alphal-adrencoptors in canine tracheal smooth muscle and mediate neuronal and humoral alpha-adrenergic contraction. Mol Pharmacol 23: 570–575
Barnes PJ, Skoogh B-E, Brown JK, Nadel J A (1983c) Activation of alpha-adrenergic responses in tracheal smooth muscle: a post-receptor mechanism. J Appl Physiol 54: 1469–1476
Barnes PJ, Grandordy BM, Page CP, Rhoden KJ, Robertson DN (1987) The effect of platelet activating factor on pulmonary beta-adrenoceptors. Br J Pharmacol 90: 709–715
Barnes PJ, Minette PA, Maclagan J (1988) Muscarinic receptor subtypes in lung. Trends Pharmacol Sci 9: 412–s416
Baudouiri SV, Aitman TJ, Johnson AJ (1988) Prazosin in the treatment of chronic asthma. Thorax 43: 385–387
Belvisi MG, Chung KF, Jackson DM, Barnes PJ (1988) Opioid modulation of non- colinergic neural bronchoconstriction in guinea-pig in vivo. Br J Pharmacol 95: 413–418
Belvisi MG, Ichinose M, Barnes PJ (1989a) Evidence for GAB A B receptors on non-adrenergic non-cholinergic nerves in guinea-pig airways. Br J Pharmacol 97: 1225–1231
Belvisi MG, Rogers DF, Barnes PJ (1989b) Neurogenic plasma extravasation:inhibition by morphine in guinea pig airways in vivo. J Appl Physiol 66: 268–272
Blaber LC, Fryer AD, Maclagan J (1985) Neuronal muscarinic receptors attenuate vagally-induced contraction of feline bronchial smooth muscle. Br J Pharmacol 86: 723–728
Bloom JW, Yamamura HI, Baumgartner C, Halonen M (1987) A muscarinic receptor with high affinity for pirenzepine mediates vagally induced bronchoconstriction. Eur J Pharmacol 133: 21–27
Bloom JW, Baumgartener-Folkerts C, Palmer JD, Yamamura HI, Halonen M (1988) A muscarinic receptor subtype modulates vagally stimulated bronchial contraction. J Appl Physiol 85: 2144–2150
Bonner TI, Buckley NJ, Young AC, Bann MR (1987) Identification of a family of muscarinic acetylcholine receptor genes. Science 237: 527–532
Bonner TI, Young AC, Brann MR, Buckley NJ (1988) Cloning and expression of the human and rat M5 muscarinic acetylcholine receptor genes. Neuron 1: 403–410
Boschetto P, Roberts NM, Rogers DF, Barnes PJ (1989) Effect of anti-asthma drugs on microvascular leakage in guinea-pig airways. Am Rev Respir Dis 139: 416–421
Boushey HA (1984) The role of the parasympathetic system in the regulation of bronchial smooth msucle. Eur J Respir Dis 65 [Suppl]: 80–90
Boushey HA, Hotzman MJ, Sheller JR, Nadel JA (1980) Bronchial hyperreactivity. Am Rev Respir Dis 121: 389–413
Brain SD, Williams TJ, Tippins JR, Morris HR, Maclntyre I (1985) Calcitonin gene-related peptide is a potent vasodilator. Nature 313: 54–56
Brown JK, Shields R, Jones C, Gold WM (1983) Augmentation of alpha-adrenergic responsiveness in trachealis muscle of living dogs. J Appl Physiol 54: 1558–1566
Cadieux A, Springall DR, Mulderry PK, Rodrigo J, Ghatei MA, Terenghi G, Bloom SR, Polak JM (1986) Occurrence, distribution and ontogeny of CGRP- immunoreactivity in the rat lower respiratory tract: effect of capsaicin treatment and surgical denervations. Neuroscience 19: 605–627
Carstairs JR, Nimm AJ, Barnes PJ (1985) Autoradiographic visualization of beta-adrenoceptor subtypes in human lung. Am Rev Respir Dis 132: 541–547
Caughey GH, Leidig F, Viro NF, Nadel JA (1988) Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase. J Pharmacol Exp Ther 244: 133–137
Cerrina J, Ladurie ML, Labat C, Raffestin B, Bayol A, Brink C (1986) Comparison of human bronchial muscle responses to histamine in vivo with histamine and isoprotenerol agonists in vitro. Am Rev Respir Dis 134: 57–61
Chung KF, Evans TW, Graf PD, Nadel JA (1985) Modulation of cholinergic neurotransmission in canine airways by thromboxane-mimetic U 46619. Eur J Pharmacol 117: 373–375
Coleridge JCG, Coleridge HM (1984) Afferent vagal C fibre innervation of the lung and airways and its functional significance. Rev Physiol Biochem Pharmacol 99: 1–110
Coles SJ, Neill KH, Reid LM (1984) Potent stimulation of glycoprotein secretion in canine trachea by substance P. J Appl Physiol 57: 1323–1327
Cryer PE (1980) Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system. N Engl J Med 303: 436–444
Danger AH J, van den Ende R, Lorenz RR, Flavahan NA, Vanhoutte PM (1987) Prejunctional betal-adrenoceptors inhibit cholinergic neurotransmission in canine bronchi. J Appl Physiol 62: 785–790
Engels F, Oosting RS, Nijkamp FP (1985) Pulmonary macrophages induce deterioration of guinea-pig tracheal p-adrenergic function through release of oxygen radicals. Eur J Pharmacol 111: 143–144
Evans TW, Dixon CMS, Clarke B, Conradson T-B, Barnes PJ (1988) Comparison of neurokinin A and substance P on cardiovascular and airway function in man. Br J Clin Pharmacol 25: 273–275
Floyer J (1968) A treatise of the asthma. Wilkins, London
Frossard N, Barnes PJ (1987) i-Opioid receptors modulate non-cholinergic constrictor nerves in guinea-pig airways. Eur J Pharmacol 141: 519–522
Frossard N, Rhoden KJ, Barnes PJ (1989) Influence of epithelium on guinea pig airway responses to tachykinins: role of endopeptidase and cyclooxygenase. J Pharmacol Exp Ther 248: 292–299
Fryer AD, Maclagan J (1984) Muscarinic inhibitory receptors in pulmonary parasymathetic nerves in the guinea-pig. Br J Pharmacol 83: 973–978
Fryer AD, Maclagan J (1987) Ipratropium bromide potentiates bronchoconstriction induced by vagal nerve stimulation in the guinea-pig. Eur J Pharmacol 139: 187–191
Fuller RW, Dixon CMS, Cuss FMC, Barnes PJ (1987a) Bradykinin-induced bronchoconstriction in man: mode of action. Am Rev Respir Dis 135: 176–180
Fuller RW, Maxwell DL, Dixon CMS, McGregor GP, Barnes VF, Bloom SR, Barnes PJ (1987b) The effects of substance P on cardiovascular and respiratory function in human subjects. J Appl Physiol 62: 1473–1479
Goldie RG, Spina D, Henry PJ, Lulich KM, Paterson JW (1986) In vitro responsiveness of human asthmatic blockers to carbachol, histamine, (3-receptor agonists and theophylline. Br J Clin Pharmacol 22: 669–676
Grandordy BM, Barnes PJ (1987) Phosphoinositide turnover in airway smooth muscle. Am Rev Respir Dis 136 [Suppl]: S17–20
Grandordy BM, Frossard N, Rhoden KJ, Barnes PJ (1988) Tachykinin-induced phosphoinositide breakdown in airway smooth muscle and epithelium: relationship to contraction. Mol Pharmacol 33: 515–519
Grandordy B, Rhoden K, Barnes PH (1990) Effects of protein kinase C activation on adrenoceptors in airway smooth muscle. Biochem Biophys Res Commun (in press)
Gross NJ (1988) Ipratropium bromide. N Engl J Med 319: 486–494
Gross NJ, Skorodin MS (1984a) Anticholinergic antimuscarinic bronchodilators. Am Rev Respir Dis 129: 856–870
Gross NJ, Skorodin MS (1984b) Role of the parasympathetic system in airway obstruction due to emphysema. N Engl J Med 311: 321–325
Grundstrom N, Andersson RGG, Wikberg JES (1981) Prejunctional alpha2- adrenoceptors inhibit contraction of tracheal smooth muscle by inhibitory cholinergic neurotransmission. Life Sci 28: 2981–2986
Hall AK, Barnes PJ, Meldrum LA, Maclagan J (1989) Facilitation by tachykinins of neurotransmission in guinea-pig pulmonary parasympathetic nerves. Br J Pharmacol 97: 274–280
Hall I, Chilvers ER (1989) Inositol phosphates and airway smooth muscle. Pulm Pharmacol 2: 113–120
Ichinose M, Barnes PJ (1989) Inhibitory histamine H3-receptors on cholinergic nerves in human airways. Eur J Pharmacol 163: 383–386
Ichinose M, Inoue H, Miura M, Takishima T (1988) Nonadrenergic bronchodilation in normal subjects. Am Rev Respir Dis 138: 31–34
Ichinose M, Stretton CD, Schwartz J-C, Barnes PJ (1989) Histamine H3-receptors inhibit cholinergic neurotransmission in guinea pig airways. Br J Pharmacol 97: 13–15
Ind PW, Brown MJ, Barnes PJ (1983) Sympathoadrenal responses in asthma. Thorax 38: 702
Ind PW, Barnes PJ, Brown MJ, Dollery CT (1985a) Plasma histamine concentration during propranolol induced bronchoconstriction. Thorax 40: 903–909
Ind PW, Causon RC, Brown MJ, Barnes PJ (1985b) Circulating catecholamines in acute asthma. Br Med J 290: 267–279
Ind PW, Dixon CMS, Fuller RW, Barnes PJ (1989) Anticholinergic blockade of beta-blocker induced bronchoconstriction. Am Rev Respir Dis 139: 1390–1394
Johnson AR, Asthon J, Schulz WW Erdos EG (1985) Neutral metalloendopeptidases in human lung tissue and cultured cells. Am Rev Respir Dis 132: 564–568
Joos G, Pauwels R, van der Straeten M (1987) Effect of inhaled substance P and neurokinin A on the airways of normal and asthmatic subjects. Thorax 42: 779–783
Kaliner MA, Barnes PJ (eds) (1988) The airways: neural control in health and disease. Dekker, New York, pp 657 (Lung biology in health and disease series, vol 33 )
Kaliner M, Shelhamer J, Davis PB, Smith LJ, Venter JC (1982) Autonomic nervous system abnormalities and allergy. Ann Intern Med 96: 349–357
Kallenbach JM, Webster T, Dowdeswell R, Reinach SG, Scott Millar RN, Zwi S (1985) Reflex heart rate control in asthma. Chest 87: 644–648
Kaufman MP, Coleridge HM, Coleridge JCG, Baker DG (1980) Bradykinin stimulates afferent vagal C-fibers in intrapulmonary airways of dogs. J Appl Physiol 48: 551–517
Kneussl MP, Richardson JB (1978) Alpha-adrenergic receptors in human and canine tracheal and bronchial smooth muscle. J Appl Physiol 45: 307–311
Laitinen A, Partanen M, Hervonen A, Peto-Huikko M, Laitinen LA (1985) VIP-like immunoreactive nerves in human respiratory tract. Light and election micrso- scopic study. Histochemistry 82: 313–319
Lammers J-W, Minette P, McCusker MT, Chung KF, Barnes PJ (1988) Nonad- renergic bronchodilator mechanisms in normal human subjects in vivo. J Appl Physiol 64: 1817–1822
Lammers J-W, Minette P, McCusker M, Barnes PJ (1989a) The role of pirenzepine- sensitive (Ml) muscarinic receptors in vagally mediated bronchoconstriction in humans. Am Rev Respir Dis 139: 446–449
Lammers J-W, Minette P, McCusker MT, Chung KF, Barnes PJ (1989b) Capsaicin; induced bronchodilation in asthmatic patients: role of the nonadrenergic inhibitory system. J Appl Physiol 67: 856–861
Larssen K, Grunneberg R, Hjemdahl P (1985) Bronchodilatation and inhibition of allergen-induced bronchoconstriction by circulatory epinephrine in asthmatic subjects. J Allergy Clin Immunol 75: 586–593
Larssen K, Martinsson A, Hjemdahl P (1986) Influence of circulating 4a-adrenoceptor agonists on pulmonary function and cardiovascular variables in patients with exercise induced asthma and healthy subjects. Thorax 41: 522–528
Lundberg JM, Saria A (1987) Polylpeptide-containing neurons in airway smooth muscle. Ann Rev Physiol 49: 557–572
Lundberg JM, Martling C-R, Saria A (1983a) Substance P and capsaicin-induced contraction of human bronchi. Acta Physipl Scand 119: 49–53
Lundberg JM, Saria A, Brodin E, Rusells S, Folkers R (1983b) A substance P antagonist inhibits vagally induced increase in vascular permeability and bronchial smooth muscle contraction in the guinea-pig. Proc Natl Acad Sci USA 80: 1120–1124
Lundberg JM, Saria A, Lundblad L, Angaard A, Martling C-R, Theodorsson- Norheim E, Stjarne P, Hokfelt T (1988) Bioactive peptides in capsaicin-sensitive C-fiber afferents of the airways: functional and pathophysiological implications. In: Kaliner MA, Barnes PJ (eds) The airways: neural control in health and disease. Dekker, New York, pp 417–445
Mak JCM, Barnes PJ (1988) Autoradiographic localization of calcitonin gene-related peptide binding sites in human and guinea pig lung. Peptides 9: 957–964
Mann JS, George CF (1985) Anticholinergic drugs in the treatment of airways disease. Br J Dis Chest 79: 209–228
Martling C-R, Theordorsson-Norheim E, Lundberg JM (1987) Occurrence and effects of multiple tachykinins: substance P, neurokinin A, neuropeptide K in human lower airways. Life Sci 40: 1633–1643
McCaig DJ (1987) Comparison of autonomic responses in the trachea isolated from normal and albumin sensitive guinea-pigs. Br J Pharmacol 92: 809–816
McCormack DG, Salonen RO, Widdicombe JG, Barnes PJ (1988) Sensory neuropeptides are potent vasodilators of canine bronchial arteries in vitro. Am Rev Respir Dis 137 [Suppl]: 369
Michoud M-C, Amyot R, Jeanneret-Grosjean A, Couture J (1987) Reflex decrease of histamine-induced bronchoconstriction after laryngeal stimulation in humans. Am Rev Respir Dis 136: 618–622
Minette PA, Barnes PJ (1988) Prejunctional inhibitory muscarinic receptors on cholinergic nerves in human and guinea-pig airways. J Appl Physiol 64: 2532–2537
Minette PA, Barnes PJ (1989) Muscarinic receptor subtypes in airways: function and clinical significance. Am Rev Respir Dis 141: 8162–8165
Minette PA, Lammers J-W, Barnes PJ (1988) Is there a defect in inhibitory muscarinic receptors in asthma? Am Rev Respir Dis 137: 239
Mitchelson F (1988) Muscarinic receptor differentiation. Pharmacol Ther 37: 357–423
Nadel JA (1980) Autonomic regulation of airway smooth muscle. In: Nadel JA (ed) Physiology and pharmacology of the airways. Dekker, New York, pp 217–257
Nadel JA, Barnes PJ (1984) Autonomic regulation of the airways. Annu Rev Med 35: 451–467
Nadel JA, Barnes PJ, Holtzman MJ (1986) Autonomic factors in the hyperreactivity of airway smooth muscle. In: Handbook of Physiology: the respiratory system, vol III. American Physiological Society, Besthesda, pp 693–702
Nichol GM, Nix A, Chung KF, Barnes PJ (1989) Characterisation of bronchoconstrictor responses to sodium metabisulphite aerosol in atopic asthmatic and non-asthmatic subjects. Thorax 44: 1009–1014
Nilsson G, Dahlberg K. Brodin E, Sundler F, Strandberg K (1977) Distribution and constrictor effect of substance P in guinea pig tracheobronchial tissue. In: von Euler US, Pernow B (eds) Substance P. Raven Press, New York, pp 57–61
Ollerenshaw SL, Jarvis DL, Woolcock AJ, Scheibner T, Sullivan CE (1989a) Substance P immunoreactive nerve fibers in airways from patients with and without asthma. Am Rev Respir Dis 139: A237
Ollerenshaw S, Jarvis D, Woolcock A, Sullivan C, Scheibner T (1989b) Absence of immunoreactive vasoactive intestinal polypeptide in tissue from the lungs of patients with asthma. N Engl J Med 320: 1244–1248
Palmer JBD, Barnes PJ (1987) Neuropeptides and airway smooth muscle function. Am Rev Respir Dis 136: S50–54
Palmer JB, Cuss FMC, Barnes PJ (1986) VIP and PHM and their role in non-adrenergic inhibitory responses in isolated human airways. J Appl Physiol 61: 1322–1328
Postma DS, Keyzer JJ, Koeter GH, Sluiter HJ, De Vries K (1985) Influence of the parasympathetic and sympathetic nervous systems on nocturnal bronchial obstruction. Clin Sci 69: 251–258
Rebuck AS, Chapman KR, Abboud R, Pare PD, Kreisman H, Wolkove N, Vickerson P (1987) Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room. Am J Med 82: 59–64
Rhoden KJ, Meldrum LA, Barnes PJ (1988) Inhibition of cholinergic neurotransmission in human airways by beta2-adrenoceptors. J Appl Physiol 65: 700–705
Richardson JB (1979) State of art. Nerve supply to the lungs. Am Rev Respir Dis 119: 785–802
Richardson J, Beland J (1976) Nonadrenergic inhibitory nervous system in human airways. J Appl Physiol 41: 764–771
Robertson DN, Rhoden KJ, Grandordy B, Page CP, Barnes PJ (1988) The effect of platelet activating factor on histamine and muscarinic receptor function in guinea-pig airways. Am Rev Respir Dis 137: 1317–1322
Rogers DF, Barnes PJ (1989) Opioid inhibition of neurally mediated mucus secretion in human bronchi. Lancet i: 930–932
Rogers DF, Belvisi MG, Aursudkij B, Evans TW, Barnes PJ (1988a) Effects and interactions of sensory neuropeptides on airway microvascular leakage in guinea pig. Br J Pharmacol 95: 1109–1116
Rogers DF, Aursudkij B, Barnes PJ (1989) Effects of tachykinins on mucus secretion in human bronchi in vitro. Eur J Pharmacol 174: 283–286
Salone RO, Webber SE, Widdicombe JG (1988) Effects of neuropeptides and capsaicin on the canine tracheal vasculature in vivo. Br J Pharmacol 95: 1262–1270
Salter HH (1868) On asthma: its pathology and treatment, 2nd edn. Churchill, London
Sands MF, Douglas FL, Green J, Banner AS, Robertson GL, Leff AR (1985) Homeostatic regulation of bronchomotor tone by sympathetic activation during bronchoconstriction in normal and asthmatic humans. Am Rev Respir Dis 132: 993–998
Saria A, Martling C-R, Yan Z, Theordorson-Norheim E, Gamse R, Lundberg JM (1988) Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethyulphenyl piperazinium and vagal nerve stimulation. Am Rev Respir Dis 137: 1330–1335
Sekizawa K, Tamaoki J, Nadel JA, Borson DB (1987) Enkephalinase inhibitor potentiates substance P and electrically induced contraction in ferret trachea. J Appl Physiol 63: 1401–1405
Sekizawa K, Caughey GH, Lazarus SK, Gold WM, Nadel JA (1989) Mast cell tryptase causes airway smooth muscle hyperresponsiveness in dogs. J Clin Invest 83: 175–179
Skidgel RA, Engelbrecht A, Johnson AR, Erdos EG (1984) Hydrolysis of substance P and neurokinins by converting enzyme and neutral endoproteinase. Peptides 5: 769–776
Szentivanyi A (1968) The beta adrenergic theory of the atopic abnormality in bronchial asthma. J Allergy 42: 203–232
Szolcsanyi J (1988) Antidromic vasodilatation and neurogenic inflammation. Agents Actions 23: 5–11
Tan WC, Cripps E, Douglas N, Sudlow MF (1982) Protective effects of drugs on bronchoconstriction induced by sulphur dioxide. Thorax 37: 671–676
Tanaka DT, Grustein MM (1986) Effect of substance P on neurally mediated contraction of rabbit airway smooth muscle. J Appl Physiol 60: 458–463
Tattersfield AE, Holgate ST, Harvey JE, Gribbin HR (1983) Is asthma due to partial beta-blockade of airways. Agents Actions 13: 265–271
Thompson JE, Scypinski LA, Gordon T, Sheppard D (1987) Tachykinins mediate the increase in airway responsiveness caused by toluene diisocynante. Am Rev Respir Dis 136: 43–49
Thomson NC (1987) In vivo versus in vitro human airway responsiveness to different pharmacologic stimuli. Am Rev Respir Dis 136: S58–62
Uddman R, Luts A, Sundler F (1985) Occurrence and distribution of calcitonin gene-related peptide in the mammalian respiratory tract and middle ear. Cell Tissue Res 241: 551–555
Ward MJ, Fentem PH, Roderick Smith WH, Davies D (1981) Ipratropium bromide in acute asthma. Br Med J 282: 590–600
Warren JB, Keynes RJ, Brown MJ, Jenner DA, McNicol MW (1982) Blunted sympathoadrenal response to exercise in asthmatic subjects. Br J Dis Chest 76: 147–150
Warren JB, Dalton N, Turner C, Clark TJH (1984) Protective effect of circulating epinephrine within the physiological range on the airway response to inhaled histamine in non-asthmatic subjects. J Allergy Clin Immunol 74: 683–686
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Barnes, P.J. (1991). Neural Mechanisms in Asthma. In: Page, C.P., Barnes, P.J. (eds) Pharmacology of Asthma. Handbook of Experimental Pharmacology, vol 98. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75855-3_5
Download citation
DOI: https://doi.org/10.1007/978-3-642-75855-3_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-75857-7
Online ISBN: 978-3-642-75855-3
eBook Packages: Springer Book Archive